Skip to main content
Figure 1 | Thyroid Research

Figure 1

From: 13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study

Figure 1

Study design. Radioiodine non-avid disease was confirmed by a negative post-therapy whole-body scan plus radiological imaging. Study day scale is not drawn proportionally. RAI, radioiodine treatment; rxWBS, post-therapy whole-body scan (* TSH, Tg, rTg, morphology, transaminase, cholesterol, creatinine. ** morphology, transaminase, cholesterol, creatinine, in 20 patients also TSH, Tg, rTg. *** TSH, Tg, rTg)

Back to article page

Thyroid Research

ISSN: 1756-6614